Toronto · Stocky rates: Avoid

CURALEAF HOLDINGS INC (CURA.TO)

C$13.73 ▲ +3.86% as of 24 Aug, 12:57

Stocky turns companies like CURALEAF HOLDINGS INC into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
19
/ 100
Avoid

What Stocky thinks

Avoid. CURA.TO scores 21/100 overall, with a weak Value Compounder Score of 20/100 indicating poor earnings quality or growth-profitability balance. Leadership Alignment at 45/100 suggests misaligned incentives or governance concerns that raise capital-allocation risk. While Vulnerability Index shows no immediate structural threats, the combination of weak fundamentals and leadership gaps outweighs any defensive qualities.

Compounder Score
16/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
45/100
Founder-led, insider ownership, capital allocation history.
Vulnerability
0/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
16/100
Valuation vs peers and history — is this a good price to pay?

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for CURALEAF HOLDINGS INC:

19
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 19/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

45
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

0
RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

CURALEAF HOLDINGS INC (CURA.TO) — frequently asked

Is CURALEAF HOLDINGS INC (CURA.TO) a good investment right now?

Stocky rates CURALEAF HOLDINGS INC (CURA.TO) at 19/100 — an Avoid — fundamentals or risks are too weak. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Avoid. CURA.TO scores 21/100 overall, with a weak Value Compounder Score of 20/100 indicating poor earnings quality or growth-profitability balance. Leadership Alignment at 45/100 suggests misaligned incentives or governance concerns that r

What is CURA.TO's Stocky Verdict?

CURA.TO's current Stocky Verdict is 19/100, placing it in the "Avoid" band. This composite combines a 16/100 Compounder score, 45/100 Leadership, Moat rating, and analyst signal.

Does CURALEAF HOLDINGS INC have a competitive moat?

Stocky hasn't finalised a Moat Score for CURALEAF HOLDINGS INC yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is CURALEAF HOLDINGS INC's leadership aligned with shareholders?

CURALEAF HOLDINGS INC scores 45/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to CURA.TO?

CURALEAF HOLDINGS INC's Vulnerability Profile scores 0/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to CURALEAF HOLDINGS INC.

This is just the surface. See the whole picture on CURALEAF HOLDINGS INC.

Sign up free and unlock the full analysis on CURA.TO — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering CURA.TO — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for CURA.TO.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how CURA.TO changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to CURA.TO?" · "Is CURA.TO overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
19
/ 100 · Avoid

See CURALEAF HOLDINGS INC the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in CURA.TO would be worth today.
Practice portfolio
Buy CURA.TO with virtual money and track it — zero risk.
Free · no real money · learn by doing Open CURA.TO in Stocky →

Or jump straight to the interactive dashboard for CURA.TO in the app.